Lv11
5 积分 2021-06-09 加入
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
1小时前
待确认
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
1小时前
已完结
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract
1个月前
已完结
Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study
1个月前
已完结
Fantastic IgA plasma cells and where to find them
2个月前
已完结
Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation
2个月前
已完结
Targeted release of budesonide in primary IgA nephropathy
2个月前
已完结
Drugs in Development to Treat IgA Nephropathy
2个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
3个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
3个月前
已完结
皖公网安备34019202002308
